ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
Tanaka I, Chakraborty A, Saulnier O, Benoit-Pilven C, Vacher S, Labiod D, Lam EWF, Bièche I, Delattre O, Pouzoulet F, Auboeuf D, Vagner S, Dutertre M.
Tanaka I, et al. Among authors: dutertre m.
Nucleic Acids Res. 2020 Mar 18;48(5):2676-2693. doi: 10.1093/nar/gkz1213.
Nucleic Acids Res. 2020.
PMID: 31943118
Free PMC article.